These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13503185)

  • 41. [Clinical aspects and therapy of vulvar carcinoma].
    BACHMANN FF
    Krebsarzt; 1954 Jun; 9(3):150-60. PubMed ID: 13202439
    [No Abstract]   [Full Text] [Related]  

  • 42. [Surgical therapy of vulvar carcinoma at the clinic in Pavia from 1949 to 1954].
    CAZZOLA D
    Wien Klin Wochenschr; 1958 Mar; 70(12):211-2. PubMed ID: 13558118
    [No Abstract]   [Full Text] [Related]  

  • 43. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.
    Woelber L; Mahner S; Voelker K; Eulenburg CZ; Gieseking F; Choschzick M; Jaenicke F; Schwarz J
    Anticancer Res; 2009 Feb; 29(2):545-52. PubMed ID: 19331201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Langerhans cells in vulvar lichen sclerosus and vulvar squamous cell carcinoma.
    Rotsztejn H; Trznadel-Budźko E; Jesionek-Kupnicka D
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):363-6. PubMed ID: 17031466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of MMP-2 in vulvar neoplasms.
    Bovo AC; da Silva ID; Takita LC; Fochi J; Stávale JN; Marks G; de Lima GR
    Gynecol Oncol; 2004 May; 93(2):454-7. PubMed ID: 15099961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
    Hampl M; Sarajuuri H; Wentzensen N; Bender HG; Kueppers V
    Obstet Gynecol; 2006 Dec; 108(6):1361-8. PubMed ID: 17138767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma.
    Bonvicini F; Venturoli S; Ambretti S; Paterini P; Santini D; Ceccarelli C; Zerbini M; Musiani M
    J Med Virol; 2005 Sep; 77(1):102-6. PubMed ID: 16032717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skin graft failure mimicking abscess masking local recurrence of vulvar cancer: a case report.
    Gungor T; Simsek A; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):239-41. PubMed ID: 18506457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis.
    Holm R; Knopp S; Kumar R; Lee J; Nesland JM; Tropè C; Callen DF
    J Clin Pathol; 2008 Jan; 61(1):59-63. PubMed ID: 17468294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bullous lesions of the vulvar region revealing both AL amyloidosis and vulvar carcinoma.
    Van De Nieuwenhof HP; Croockewit AJ; Van Der Avoort IA; Bekkers RL; De Hullu JA
    Amyloid; 2008 Sep; 15(3):210-2. PubMed ID: 18925460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent vulvar lymphangitis cured with vulvectomy in a cervical carcinoma patient: a case report.
    Micha JP; Goldstein BH; Rettenmaier MA; Tinnerman-Minailo EJ; Brown JV; McClellan SN; Bock BV
    J Reprod Med; 2008 Apr; 53(4):299-301. PubMed ID: 18472655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary cancer of the vulva.
    GYLLING T
    Ann Chir Gynaecol Fenn Suppl; 1958; 47(81):17-29. PubMed ID: 13606444
    [No Abstract]   [Full Text] [Related]  

  • 54. Vulvar cancer and the need for awareness of precursor lesions.
    Maclean AB; Jones RW; Scurry J; Neill S
    J Low Genit Tract Dis; 2009 Apr; 13(2):115-7. PubMed ID: 19387133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Association of radiotherapy and chemotherapy: targeted therapies in gynecological cancers].
    Barillot I; Haie-Meder C
    Bull Cancer; 2009 Mar; 96(3):271-83. PubMed ID: 19318305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical advantages of the 22-million-volt betatron.
    LOEFFLER RK; SCOTT KW
    Miss Valley Med J; 1957 Nov; 79(6):253-8. PubMed ID: 13483405
    [No Abstract]   [Full Text] [Related]  

  • 57. [Our experience with vulvae carcinoma].
    TAPFER S
    Wien Med Wochenschr; 1954 Apr; 104(15):299-301. PubMed ID: 13169840
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experiments with 31-MeV-betatron and the further development of asklepitron].
    SCHINZ HR
    Fortschr Geb Rontgenstr Nuklearmed; 1957 Jan; 86(1):104-13. PubMed ID: 13414942
    [No Abstract]   [Full Text] [Related]  

  • 59. [Three years' experience with the 15 MeV Siemens betatron].
    BECKER J; WEITZEL G
    Strahlentherapie; 1956 Oct; 101(2):167-79. PubMed ID: 13391347
    [No Abstract]   [Full Text] [Related]  

  • 60. [Practical aspects of application of betatron to radiotherapy].
    BELLION B; TRIBUNO C
    Minerva Med; 1957 Mar; 48(23):963-71. PubMed ID: 13430523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.